479 related articles for article (PubMed ID: 8842498)
1. A systems approach to cancer therapy. (Antioncogenics + standard cytotoxics-->mechanism(s) of interaction).
Teicher BA
Cancer Metastasis Rev; 1996 Jun; 15(2):247-72. PubMed ID: 8842498
[No Abstract] [Full Text] [Related]
2. Angiogenesis inhibitors in combinatorial approaches.
Nowak-Sliwinska P; Griffioen AW
Angiogenesis; 2017 May; 20(2):183-184. PubMed ID: 28382510
[No Abstract] [Full Text] [Related]
3. Angiogenesis and cancer metastases: therapeutic approaches.
Teicher BA
Crit Rev Oncol Hematol; 1995 Aug; 20(1-2):9-39. PubMed ID: 7576200
[No Abstract] [Full Text] [Related]
4. Angiogenesis. A boost for tumor starvation.
Marx J
Science; 2003 Jul; 301(5632):452-4. PubMed ID: 12881543
[No Abstract] [Full Text] [Related]
5. CANCER. Tumor angiogenesis, from foe to friend.
Rivera LB; Bergers G
Science; 2015 Aug; 349(6249):694-5. PubMed ID: 26273044
[No Abstract] [Full Text] [Related]
6. [Inhibition of angiogenesis by proteins, peptides and "small molecules"].
Jayson G; Armand JP; Berdel WE
Onkologie; 2005 Oct; 28 Suppl 4():29-34. PubMed ID: 16205103
[No Abstract] [Full Text] [Related]
7. Potential of DMXAA combination therapy for solid tumors.
Baguley BC; Wilson WR
Expert Rev Anticancer Ther; 2002 Oct; 2(5):593-603. PubMed ID: 12382527
[TBL] [Abstract][Full Text] [Related]
8. Antiangiogenic strategies and agents in clinical trials.
Rosen L
Oncologist; 2000; 5 Suppl 1():20-7. PubMed ID: 10804087
[TBL] [Abstract][Full Text] [Related]
9. Statins use and cancer: an update.
Zaleska M; Mozenska O; Bil J
Future Oncol; 2018 Jun; 14(15):1497-1509. PubMed ID: 29722274
[TBL] [Abstract][Full Text] [Related]
10. Metronomic therapy from a pharmacologist's view.
Kamen BA; Glod J; Cole PD
J Pediatr Hematol Oncol; 2006 Jun; 28(6):325-7. PubMed ID: 16794497
[No Abstract] [Full Text] [Related]
11. Antiangiogenic therapy: a universal chemosensitization strategy for cancer?
Kerbel RS
Science; 2006 May; 312(5777):1171-5. PubMed ID: 16728631
[TBL] [Abstract][Full Text] [Related]
12. Metronomic therapy: it makes sense and is patient friendly.
Kamen BA
J Pediatr Hematol Oncol; 2005 Nov; 27(11):571-2. PubMed ID: 16282885
[No Abstract] [Full Text] [Related]
13. Angiogenesis research. Cancer drugs found to work in new way.
Barinaga M
Science; 2000 Apr; 288(5464):245. PubMed ID: 10777399
[No Abstract] [Full Text] [Related]
14. Anticancer therapy with angiogenesis inhibitors.
Ghilardi C; Bani MR; Giavazzi R
Tumori; 2001; 87(6):S14-6. PubMed ID: 11989610
[No Abstract] [Full Text] [Related]
15. Metformin and Angiogenesis in Cancer - Revisited.
Kannarkatt J; Alkharabsheh O; Tokala H; Dimitrov NV
Oncology; 2016; 91(4):179-184. PubMed ID: 27487294
[TBL] [Abstract][Full Text] [Related]
16. [Angiogenesis as a target for antitumor actions].
Ushmorov AG; Aleksandrov VA
Vopr Onkol; 1989; 35(3):263-70. PubMed ID: 2468258
[No Abstract] [Full Text] [Related]
17. Vascular normalization: a real benefit?
Ribatti D
Cancer Chemother Pharmacol; 2011 Aug; 68(2):275-8. PubMed ID: 21638121
[TBL] [Abstract][Full Text] [Related]
18. Despite checkered past, thalidomide and its analogues show potential.
Friedrich MJ
J Natl Cancer Inst; 2002 Sep; 94(17):1270-2. PubMed ID: 12208890
[No Abstract] [Full Text] [Related]
19. American Society of Clinical Oncology-39th Annual Meeting. Angiogenesis. 31 May-3 June 2003, Chicago, IL, USA.
Erlich R; Durrance A
IDrugs; 2003 Jul; 6(7):623-4. PubMed ID: 12906003
[No Abstract] [Full Text] [Related]
20. Tumour vasculature targeting agents in hybrid/conjugate drugs.
Prokopiou EM; Ryder SA; Walsh JJ
Angiogenesis; 2013 Jul; 16(3):503-24. PubMed ID: 23543223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
